• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测潜伏性结核感染治疗未完成情况:一项前瞻性调查。

Predicting non-completion of treatment for latent tuberculous infection: a prospective survey.

作者信息

Shieh Fred K, Snyder Graham, Horsburgh C Robert, Bernardo John, Murphy Claire, Saukkonen Jussi J

机构信息

Pulmonary Center, Boston University School of Medicine, 80 East Concord Street, R-304, Boston, MA 02118, USA.

出版信息

Am J Respir Crit Care Med. 2006 Sep 15;174(6):717-21. doi: 10.1164/rccm.200510-1667OC. Epub 2006 Jun 29.

DOI:10.1164/rccm.200510-1667OC
PMID:16809632
Abstract

UNLABELLED

Treatment of latent tuberculosis (TB) infection (LTBI) is essential for the elimination of TB in the United States, but treatment is often not completed. Little is known about patients' reasons for not completing treatment. We hypothesized that certain health beliefs, lifestyle, and clinic- and regimen-related barriers to provision of care could predict non-completion of LTBI treatment.

METHODS

We administered a survey in English, Chinese, or Spanish to patients with LTBI at the first TB clinic visit. Using chi(2) and logistic regression analysis, we assessed demographics, TB risk factors, and survey responses as predictors of non-completion of 6 mo of isoniazid.

RESULTS

217 patients, 90% foreign-born, completed the survey, and 28.6% of which finished at least 6 mo of isoniazid under usual clinic conditions. Multivariate analysis identified two independent predictors of non-completion: low risk perception of progressing to active TB without LTBI treatment (odds ratio [OR], 0.31 [0.13-0.72], 95% confidence interval [CI]), p = 0.007, accounting for 20% of non-completers, and not wanting venipuncture (OR, 0.43 [0.22-0.85], 95% CI), p = 0.015, accounting for 37% of non-completers. Another 18% shared both predictors; thus these two predictors accounted for 75% of non-completers in total.

CONCLUSIONS

Patients assess LTBI treatment risks and inconveniences relative to low perceived benefits at treatment outset. Predictors of LTBI treatment non-completion are identifiable at the first visit. Targeting TB high-risk individuals, minimizing inconveniences, further education, and use of diagnostic tests with improved specificity for TB may address these concerns.

摘要

未标注

在美国,治疗潜伏性结核感染(LTBI)对于消除结核病至关重要,但治疗往往无法完成。对于患者未完成治疗的原因知之甚少。我们假设某些健康观念、生活方式以及与诊所和治疗方案相关的护理障碍可能会预测LTBI治疗的未完成情况。

方法

我们在患者首次就诊于结核病诊所时,用英语、中文或西班牙语对LTBI患者进行了一项调查。使用卡方检验和逻辑回归分析,我们评估了人口统计学特征、结核病风险因素以及调查回复,将其作为未完成6个月异烟肼治疗的预测因素。

结果

217名患者完成了调查,其中90%出生于国外,在常规诊所条件下,28.6%的患者完成了至少6个月的异烟肼治疗。多变量分析确定了两个未完成治疗的独立预测因素:认为不进行LTBI治疗进展为活动性结核病的风险较低(优势比[OR],0.31[0.13 - 0.72],95%置信区间[CI]),p = 0.007,占未完成治疗者的20%;以及不想接受静脉穿刺(OR,0.43[0.22 - 0.85],95%CI),p = 0.015,占未完成治疗者的37%。另外18%的患者同时具备这两个预测因素;因此这两个预测因素总共占未完成治疗者的75%。

结论

患者在治疗开始时会评估LTBI治疗的风险和不便之处,相对于较低的感知益处而言。LTBI治疗未完成的预测因素在首次就诊时即可识别。针对结核病高危个体、尽量减少不便之处、进一步开展教育以及使用对结核病特异性更高的诊断测试可能会解决这些问题。

相似文献

1
Predicting non-completion of treatment for latent tuberculous infection: a prospective survey.预测潜伏性结核感染治疗未完成情况:一项前瞻性调查。
Am J Respir Crit Care Med. 2006 Sep 15;174(6):717-21. doi: 10.1164/rccm.200510-1667OC. Epub 2006 Jun 29.
2
Incidence of TB in inmates with latent TB infection: 5-year follow-up.潜伏性结核感染囚犯中的结核病发病率:5年随访
Am J Prev Med. 2005 Nov;29(4):295-301. doi: 10.1016/j.amepre.2005.06.014.
3
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.1993年至2003年美国的异烟肼单耐药结核病
Arch Intern Med. 2008 Oct 13;168(18):1984-92. doi: 10.1001/archinte.168.18.1984.
4
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.利福平与异烟肼治疗潜伏性结核的依从性改善及毒性降低:一项回顾性研究
Arch Intern Med. 2006 Sep 25;166(17):1863-70. doi: 10.1001/archinte.166.17.1863.
5
Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.巴西萨尔瓦多潜伏性结核感染治疗疗程未完成的风险因素
Int J Tuberc Lung Dis. 2009 Jun;13(6):719-25.
6
Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.在纽约市临床人群中治疗潜伏性结核感染的坚持情况。
Int J Infect Dis. 2010 Apr;14(4):e292-7. doi: 10.1016/j.ijid.2009.05.007. Epub 2009 Aug 4.
7
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.使用利福平治疗4个月提高潜伏性结核感染的治疗完成率。
Chest. 2006 Dec;130(6):1712-7. doi: 10.1378/chest.130.6.1712.
8
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.挪威潜伏性结核感染的治疗完成情况:一项前瞻性队列研究。
BMC Infect Dis. 2018 Nov 19;18(1):587. doi: 10.1186/s12879-018-3468-z.
9
The impact of smoking on adherence to treatment for latent tuberculosis infection.吸烟对潜伏性结核感染治疗依从性的影响。
BMC Public Health. 2006 Mar 14;6:66. doi: 10.1186/1471-2458-6-66.
10
Treatment guidelines for latent tuberculosis infection.潜伏性结核感染的治疗指南。
Kekkaku. 2014 Jan;89(1):21-37.

引用本文的文献

1
Factors associated with incomplete latent tuberculosis infection preventive treatment in Sabah, Malaysia.马来西亚沙巴州与潜伏性结核感染预防性治疗不完整相关的因素。
PeerJ. 2025 Jul 29;13:e19736. doi: 10.7717/peerj.19736. eCollection 2025.
2
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.全球移民潜伏性结核感染治疗的启动和完成:系统评价和荟萃分析。
Lancet Infect Dis. 2021 Dec;21(12):1701-1712. doi: 10.1016/S1473-3099(21)00052-9. Epub 2021 Aug 4.
3
Caregivers' knowledge and perceptions are associated with children's TB preventive treatment completion.
照顾者的知识和认知与儿童结核病预防性治疗的完成情况相关。
Public Health Action. 2021 Jun 21;11(2):85-90. doi: 10.5588/pha.21.0009.
4
Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.美国潜伏性结核感染居民自我报告的护理参与度:2011-2012 年。
Ann Am Thorac Soc. 2021 Oct;18(10):1669-1676. doi: 10.1513/AnnalsATS.202009-1153OC.
5
Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.日本移民潜伏性结核感染的趋势和治疗结果:日本结核病监测数据的回顾性分析。
BMC Infect Dis. 2021 Jan 9;21(1):42. doi: 10.1186/s12879-020-05712-1.
6
Gaps in the care cascade for screening and treatment of refugees with tuberculosis infection in Middle Tennessee: a retrospective cohort study.田纳西州中部分区针对结核感染的筛查和治疗,在护理连续体方面存在的差距:一项回顾性队列研究。
BMC Infect Dis. 2020 Aug 10;20(1):592. doi: 10.1186/s12879-020-05311-0.
7
Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.通过与社区药店和卫生部门合作的护理模式解决潜伏性结核感染治疗问题。
Prev Chronic Dis. 2020 Feb 13;17:E14. doi: 10.5888/pcd17.190263.
8
Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.潜伏性结核感染治疗病例中治疗指征、结核菌素皮肤试验及卡介苗接种瘢痕的评估
Turk Thorac J. 2018 Jan;19(1):7-12. doi: 10.5152/TurkThoracJ.2017.17027. Epub 2017 Sep 27.
9
Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.日本潜伏性结核感染患者的趋势及治疗状况——基于日本结核病监测数据的分析
PLoS One. 2017 Nov 1;12(11):e0186588. doi: 10.1371/journal.pone.0186588. eCollection 2017.
10
Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.医护人员潜伏性结核感染的管理:单中心 10 年经验。
Clin Infect Dis. 2017 Nov 29;65(12):2105-2111. doi: 10.1093/cid/cix725.